The gene-expression signatures of BRAF- and KRAS-mutated tumors typifying the CMS subtypes have been observed in adenomas, the precursors of CRC, indicating that these gene-expression patterns are early changes during CRC evolution that occur before acquisition of all of the relevant cancer-driver mutations [32, 42] (Figure 2). This evidence concerns the gene KRAS and colorectal carcinoma.